Finally, aiming for an off-the-shelf approach in future therapeutic applications, we defined events as “shared” if they were commonly found in ≥ 10% cases in any of the disease groups (IDHwt, IDH-A, or IDH-O) within the TCGA-glioma dataset, resulting in 66 events retained. This evidence concerns the gene IDH1 and central nervous system cancer.